Authors
Latest:
My DM told me there'd be days like these…Everyone has bad days, but do you know how to make the best of them?
Latest:
Time to Step UpThe economy is turning around; leaders need to position their companies now for the market bounce.
Latest:
Helping Patients Lead the Way in the New NHSNHS England is currently undergoing profound changes to introduce a new culture where clinicians and patients are the new stars, where competition is mandatory, where everything rests on patient outcomes and where collaboration and innovation are being encouraged at the highest levels of command.
Latest:
Lack of Multichannel Confidence: A Step on the Road to Digital MaturityI’ve been lucky enough to get a sneak preview of Across Health’s 2014 Multichannel Barometer report.
Latest:
Special Report: Platform Drugs—Opportunities in the Market...How to stretch that portfolio to make ends meet
Latest:
Harbingers of ChangeThe industry is a-changing. Here are eight seminal events that describe how.
Latest:
Bridging Industry's Charisma ChasmPharma’s image is still suffering despite a rise in medical innovation. Dan Bobear offers five patient-centered strategies that could help in finally mending the gap.
Latest:
Valuing DiversityVeteran salesperson Reggie Smith of Genentech makes the case for sales force diversity
Latest:
The Changing World of Med EdFor years, medical education activities have been a sure way for pharma marketers to deliver key messages to the medical community about scientific discoveries, new treatments, and products fostering medical advancement. The most effective activities advance physicians' knowledge and motivate them to act.
Latest:
Generics Battle Heats UpThe competition for generics' 180-day marketing exclusivity is fierce, and Dr. Reddy's Laboratories filed the first court case calling into question FDA's methods for determining exclusivity on a patent-by-patent basis.
Latest:
Same Rod, Bigger FishAs pharmaceutical companies look to emerging markets to offset slowed growth at home, success will depend on efficient re-use of regulatory content to target new high-growth markets.
Latest:
Product Launch Strategies: Adapting Approaches in 2020 and BeyondWith new access levers emerging, positioning products will require a shift form the traditional launch playbook.
Latest:
Putting Predictive Market Research to the TestThere's a temptation for companies to view predictive markets as a silver bullet. Can crowds actually do a better job than "experts," or is that viewpoint more of a fad than a foundation for accurate future forecasting?
Latest:
How Not to Handle RebatesIn these cost cutting times, no drugmaker can afford to keep shoveling money down the Rebate Black Hole. Here's how to optimize your ROI and push back against the growing pressure of third-party rebates
Latest:
GSW Worldwide for MGI Pharma/Eisai's PONVTo educate anesthesiologists that post-operative nausea and vomiting (PONV) is "no fun for anyone," GSW Worldwide created WoozyWorld.com, a "non-amusement" that highlights the need for MGI Pharma's 72-hour antiemetic Aloxi.
Latest:
Decision Making at Digital SpeedIn an era in which companies can forfeit $1 million each day they delay a product launch-and being second can mean failure-pharma executives are under pressure to make risk and opportunity decisions in less time than ever.
